Pravin T. Kaumaya PhD

Current Publications

• Miller MJ, Foy KC, Kaumaya PTCancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.Discov Med 15(82) 166-76 3/1/2013
• Foy KC, Miller MJ, Moldovan N, Bozanovic T, Carson Iii WE, Kaumaya PTImmunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer.Oncoimmunology 1(7) 1004-1016 10/1/2012
• Foy KC, Miller MJ, Moldovan N, Carson Iii WE, Kaumaya PTCombined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo.Oncoimmunology 1(7) 1048-1060 10/1/2012
• Kaumaya PT, Foy KCPeptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.Future Oncol 8(8) 961-87 8/1/2012